MX2012012712A - A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. - Google Patents
A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease.Info
- Publication number
- MX2012012712A MX2012012712A MX2012012712A MX2012012712A MX2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A MX 2012012712 A MX2012012712 A MX 2012012712A
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- pharmaceutical composition
- patient
- preventing
- treating
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient, wherein the method comprises providing a pharmaceutical composition containing a therapeutically effective amount of soluble Fc.gamma.R; administering said composition to a patient, followed by a safety period of several weeks, followed by a subsequent treatment cycle of at least two weekly administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. Further to a pharmaceutical composition in the form of a multiple-dosage-kit which contains sufficient amounts of administration doses of soluble Fc.gamma.R for effectively treating or preventing inflammatory diseases and/or autoimmune diseases in a patient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012012712A MX341960B (en) | 2012-10-31 | 2012-10-31 | A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012012712A MX341960B (en) | 2012-10-31 | 2012-10-31 | A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012012712A true MX2012012712A (en) | 2014-04-30 |
MX341960B MX341960B (en) | 2016-09-08 |
Family
ID=51213278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012012712A MX341960B (en) | 2012-10-31 | 2012-10-31 | A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX341960B (en) |
-
2012
- 2012-10-31 MX MX2012012712A patent/MX341960B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MX341960B (en) | 2016-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ725006A (en) | Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns | |
MX2022013172A (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia. | |
JO3784B1 (en) | Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer | |
EA201270221A1 (en) | TREATMENT OF CROWN DISEASE WITH LACQUINIMODE | |
EA201490377A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE | |
ECSP14012676A (en) | CARBAMATE COMPOUNDS AND THE PREPARATION AND USE OF THEM | |
MX2019012884A (en) | Combination therapy. | |
BR112015010396A2 (en) | combination therapy | |
NZ703940A (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
MX2014002171A (en) | Combination treatments for hepatitis c. | |
WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
WO2016090024A3 (en) | Combination therapy for treatment of cancer | |
WO2012079093A3 (en) | Dosage and administration of bispecific scfv conjugates | |
MX2018013715A (en) | Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid. | |
MX2016006179A (en) | Aqueous based capsaicinoid formulations and methods of manufacture and use. | |
WO2012142615A3 (en) | Auranofin and auranofin analogs useful to treat proliferative disease and disorders | |
EA201370230A1 (en) | NEW ROCK INHIBITORS | |
EA201490516A1 (en) | BIFENILKARBOXYAMIDES AS ROCK KINAZ INHIBITORS | |
MX2015016418A (en) | Dihydroetorphine for the provision of pain relief and anaesthesia. | |
TW201129361A (en) | Methods for treating pain | |
MX2012012712A (en) | A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease. | |
PH12015502465A1 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
MX358512B (en) | Methods of maintaining, treating or improving cognitive function. | |
TW201613599A (en) | Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease | |
WO2013181217A3 (en) | Novel compounds and compositions for treatment of breathing control disorders or diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |